StockVS

Churchill Capital Corp IX (CCIXU) Aandelenanalyse

Financiële Diensten

Churchill Capital Corp IX

$10.84

+$0.00 (+0.00%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

Churchill Capital Corp IX is a special purpose acquisition company that does not currently engage in significant operational activities, focusing instead on executing a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or a similar business combination with one or more target businesses. The company operates within the Financial Services sector and specifically within the industry of Shell Companies, a classification that denotes entities formed primarily to acquire another company rather than to maintain ongoing independent business operations. As of the latest available data, the company's market capitalization and annual revenue are not disclosed in the provided financial metrics, and the specific employee count is listed as unavailable. These valuation gaps and the lack of traditional operational revenue streams are typical characteristics of shell companies in their pre-merger phase, indicating that the entity's position is currently defined by its potential for future business combination rather than by established market share or historical financial performance.

Financiële gezondheid

The reported financial figures show a Net Income of $8.56M for the trailing twelve months, while Revenue and EBITDA are marked as not available, suggesting a cost structure where income is generated through financing arrangements rather than operational sales. The Free Cash Flow stands at $-2,085,372, which indicates a negative cash generation capability that reflects the cash outflows associated with the company's operational setup or financing costs before potential future mergers. All three margin metrics—Gross Margin, Operating Margin, and Profit Margin—are reported at 0.0%, which signifies that the company has not yet realized operational profits from traditional business activities. In terms of liquidity and leverage, the company holds $2,469 in cash against $0 in debt, resulting in a Debt to Equity ratio that is not applicable, and this absence of debt suggests a conservative balance sheet structure free from interest-bearing liabilities. The Current Ratio is listed at 0.94, a figure below 1.0 that technically indicates the company's current assets are slightly lower than its current liabilities, though this metric holds limited interpretive value for a SPAC without standard inventory or accounts receivable. Return on Equity is not applicable, while Return on Assets is recorded at -0.8%, a negative metric that reveals the assets are currently not generating sufficient returns to cover the costs of capital employed by shareholders.

Waarderingsbeoordeling

The P/E Ratio (TTM) and Forward P/E are both not available, meaning that standard earnings-based valuation multiples cannot be calculated due to the lack of positive or substantial net income in the traditional sense for a shell entity. The Price to Book ratio is reported at -39.45, a negative figure that indicates the market capitalization is significantly below the book value of equity, a scenario often seen in SPACs where the trust account value exceeds the market price of the stock. The Price to Sales ratio and EV/EBITDA are also not available, as the company lacks the revenue and earnings data required to calculate these alternative valuation metrics. Regarding price volatility and trading range, the 52-Week High is $12.50 and the 52-Week Low is $10.50, placing the current trading price somewhere within this band depending on real-time market conditions. The Beta value is not available, which prevents a direct comparison of the stock's price volatility relative to the broader market index. Investors analyzing the valuation must rely heavily on the Price to Book metric as the primary indicator of value, as traditional multiples like P/E are irrelevant for a company with no significant operations.

Growth & Income

The Revenue Growth (YoY) and Earnings Growth (YoY) figures show a significant decline in earnings growth of -18.4%, while revenue growth is not available due to the lack of operational sales history. This negative earnings growth rate implies a contraction in profitability, likely driven by the costs associated with maintaining the shell company structure rather than operational expansion. The company does not pay dividends, as the Dividend Yield and Payout Ratio are both not available, indicating that all available earnings are retained or utilized for the purpose of seeking a merger rather than being distributed to shareholders. Consequently, the overall growth and income profile is characterized by a lack of current income generation and a reliance on future capital appreciation resulting from a successful business combination rather than organic business growth or dividend yields. The financial data underscores that the company's value proposition is entirely contingent on the execution of its merger strategy rather than on current financial performance or shareholder returns.

Vergelijking met sectorgenoten

Churchill Capital Corp IX (CCIXU) is actief in de Lege Vennootschappen-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
Churchill Capital Corp IX CCIXU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

De gemiddelde K/W-verhouding in de Lege Vennootschappen-sector is 82.8x. Churchill Capital Corp IX wordt verhandeld tegen een K/W van N/A.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over Churchill Capital Corp IX

Churchill Capital Corp IX does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Churchill Capital Corp IX was incorporated in 2023 and is based in New York, New York.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Bezoek website →

Belangrijke Cijfers

Marktkapitalisatie
N/A
K/W-verhouding
N/A
52-weken hoog
$12.50
52-weken laag
$10.50
Gem. Volume
8

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United States